Files in This Item:


Title: Immune response to measles vaccine after mass vaccination in Urmia, Islamic Republic of Iran
Authors: Yekta, Z.
Pourali, R.
Taravati, M.R.
Shahabi, S.
Salary, S.
Khalily, F.
Farzin, A.
Issue Date: 2009
Language: English
Abstract: We investigated the effectiveness of the mass measles vaccination campaign in Urmia, Islamic Republic of Iran, by examining the measles IgG seroprevalence and antibody response from paired data before and after the campaign. The overall seropositive rate of 624 subjects aged 5-25 years increased 1 year after the mass vaccination [from 53.0% to 72.3%]. A rise in antibody titre occurred in all age groups except the 21-25 years group, which had the highest titre before mass vaccination. On logistic regression analysis, only immune status prior to vaccination was significantly associated with the seroresponse. It may be cost-effective to check antibody titres before mass vaccinations, especially in high vaccine coverage regions with circulating wild virus
Description: 516-525
Keywords: Mass Immunization
Immunoglobulin G
Seroepidemiologic Studies
Cost-Benefit Analysis
Enzyme-Linked Immunosorbent Assay
Age Factors
Subject: Measles Vaccine
ISSN: 1020-3397
Other Identifiers:
Appears in Collections:EMRO Journal Articles (EMHJ)

Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.